Pricing Log in Create free account

Conexeu Sciences Inc. (CNXU) vs Champions Oncology, Inc. (CSBR)

Conexeu Sciences Inc. and Champions Oncology, Inc. are both Biotechnology companies. Conexeu Sciences Inc. and Champions Oncology, Inc. are of similar size ($66.3M and $65.4M). Conexeu Sciences Inc. has the higher net margin (0.00% vs −1.87%) and the higher return on invested capital (−234.6% vs −626.2%). Across the 12 metrics below, Conexeu Sciences Inc. leads on 6 and Champions Oncology, Inc. on 6.

Valuation

Metric CNXU CSBR Biotechnology median
P/E n/m n/m 10.26
P/S n/m 1.10 9.18
P/B 9.64 14.93 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 200.35 0.65
EV/Sales n/m 1.03 8.98
Earnings yield (29.81%) (1.67%) (34.89%)
Free cash flow yield (18.82%) (9.18%) (24.52%)

Profitability

Metric CNXU CSBR Biotechnology median
Gross margin — 49.82% 65.16%
Operating margin 0.00% (1.68%) 0.00%
Net margin 0.00% (1.87%) 0.00%
Free cash flow margin 0.00% (10.08%) 0.00%
Return on equity (458.40%) (28.38%) (50.12%)
Return on assets (354.37%) (3.56%) (45.60%)
Return on invested capital (234.60%) (626.23%) 0.00%

Growth

Metric CNXU CSBR Biotechnology median
Revenue growth (TTM) — 6.65% 6.26%
EPS growth (last fiscal year) (342.80%) (124.24%) 29.88%
Revenue growth, 5-year CAGR — 7.68% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CNXU CSBR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.31 1.03 4.89
Net debt to EBITDA 1.23 (20.56) 1.01

Dividend

Metric CNXU CSBR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CNXU CSBR Biotechnology median
Market cap 65.36m 66.26m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack